Introduction: The phlebotropic effect of flavonoids is contradictory, and clinically significant effects are poorly understood theoretically. The efficiency of flavonoids needs verification by means of the large-scale experimental and clinical trials protected from the conflicts of interest. Research Tasks: Experimental study of venotonic, anti-aggregation and endothelioprotectiv properties of the drug Detralex 1000 mg. Materials and Methods: A venotonic effect was investigated after week administration of drug inside on model of the endoteliumdependent smooth muscle response to increased calcium ion isolated portal vein of rats. The Biopac Bas System Station installation including a polygraph of Biopac MP 150 with the TSD-104A module and the software of ACQ 4.2 was for this purpose used. The protective properties of the endothelium were studied on a 7-day model of L-N-nitro-L-arginine-methyl ether-induced rat endothelial dysfunction using invasive blood pressure recording. Aggregation of thrombocytes (AT) was investigated by a visual micromethod with use as inductors ADF, a collagen, thrombinum, ristomycinum, and adrenaline. Results: In model of endothelial dysfunction rising of sensitivity to the contractile response to Сa 2 + the isolated segment of a portal vein after use of the drug Detralex of 500 mg/kg per day, and also elongation of AT and decrease of coefficient of endothelial dysfunction on a background the course reception of the investigated preparation. Conclusion: Pleiotropic effect of micronized combination of diosmin and hesperidin, expressed in strengthening the contractile potential of smooth muscle veins, improving endothelial function, and lengthening thrombocyte aggregation, was сonfirmed.